drugset / Trial / NCT00669994

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections

NCT00669994

Phase 4 Completed 180 enrolled Bayer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial evaluated how effective and safe Cipro XR was in treating female patients with signs and symptoms of a lower urinary tract infections. After 3 days of treatment, patients were evaluated to determine if signs/symptoms disappeared and the infecting bacteria was eliminated.

Timeline

Start
2003-07
Primary completion
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 500 mg